NUVL
Nuvalent IncNASDAQ
Healthcare • Biotechnology
NUVL is not an active listing in our security master. Figures below are historical and may be incomplete; insider, red-flag and holder tracking does not cover it.
$123.96+0.02%
Close Jul 14, 2026
- Market cap
- —
- 1 month
- +0.4%
- 3 months
- +19.5%
- 1 year
- +53.2%
- 52-week range
- $72.16$123.96
- Dividend
- No dividends on record
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if NUVL is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
Smart money context
Holder IQ: MEDIUM
60 smart-money holders: institutions with a high Holder IQ
Q2 2026, filed Sep 23, 2026
Smart-money 13F trend: distributing (heavy)
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: unknown
Insider trades are not tracked for an inactive listing.
Read the insider context evidence
What it means for you
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
What happened
No directional recent-activity label is available. This context label is separate from the scored insider signal read.
Why it can matter
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
How we got this
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Where the data comes from
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Largest 13-F holders · Q2 2026
293 filers reported a long position in NUVL for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
The top 10 hold
60.9%
of the 75.3M shares 13-F filers reported
Moves vs Q1 2026
7 added0 trimmed
2 new · 1 unchanged
Net shares held
+13.7%
across the 8 holders with a comparable Q1 2026 book
| Rank | Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|---|
| 1 | Deerfield Management Company, L.P. | $2.1B · 17.2M shares | 17.2M | Unchanged |
| 2 | Paradigm Biocapital Advisors LP | $731.7M · 5.9M shares | 5.9M | +11.3% |
| 3 | BlackRock, Inc. | $689.8M · 5.6M shares | 5.6M | +15.8% |
| 4 | HBK Investments L P | $430.2M · 3.5M shares | 3.5M | New |
| 5 | FIL Ltd | $363.9M · 2.9M shares | 2.9M | +4,532,986.2% |
| 6 | Vanguard Portfolio Management LLC | $319.8M · 2.6M shares | 2.6M | +3.5% |
| 7 | Vanguard Capital Management LLC | $303.7M · 2.5M shares | 2.5M | +1.3% |
| 8 | State Street Corp | $258.2M · 2.1M shares | 2.1M | +2.7% |
| 9 | Deep Track Capital, LP | $220.2M · 1.8M shares | 1.8M | +29.6% |
| 10 | Glazer Capital, LLC | $218.6M · 1.8M shares | 1.8M | New |
Sign in to see each holder’s Holder IQ, factor-adjusted Holder IQ and rank, and compare these holders with all scored filers. Available on every plan.
Sign inGet the Full Analysis for NUVL
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.